You are here

Article Text

Article menu
Download PDFPDF
Original Articles
Immunohistochemical study of p185 HER2 and DF3 in primary breast cancer and correlation with CA-15-3 serum tumor marker
  1. C Dimas1,
  2. M Frangos-Plemenos2,
  3. E Kouskouni1 and
  4. A Kondis-Pafitis2
  1. 1 Departments of Microbiology and
  2. 2 Pathology, Athens Medical School, Areteion Hospital, Athens, Greece

Abstract

Abstract. Dimas C, Frangos-Plemenos M, Kouskouni E, Kondis-Pafitis A. Immunohistochemical study of p185 HER2 and DF3 in primary breast cancer and correlation with CA-15-3 serum tumor marker.

Human epidermal growth factor receptor 2 (p185 HER2) oncoprotein immunohistochemical expression and DF3 antigen distribution were evaluated in 129 patients with primary breast cancer. p185 HER2 overexpession was positively correlated with the degree of differentiation, metastatic disease, progesterone receptors, and cytoplasmic distribution of DF3 antigen. p185 HER2 overexpression had prognostic significance for the disease-free interval.

  • breast cancer
  • DF3
  • HER2
  • immunohistochemistry
  • p185
  • tumor marker

https://doi.org/10.1136/ijgc-00009577-200201000-00012

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.